These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 22129679)
1. Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies. Kaja S; Hilgenberg JD; Everett E; Olitsky SE; Gossage J; Koulen P Hum Antibodies; 2011; 20(3-4):95-101. PubMed ID: 22129679 [TBL] [Abstract][Full Text] [Related]
2. ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia. Dupuis-Girod S; Ambrun A; Decullier E; Samson G; Roux A; Fargeton AE; Rioufol C; Schwiertz V; Disant F; Chapuis F; Donazzolo Y; Paintaud G; Edery P; Faure F MAbs; 2014; 6(3):794-9. PubMed ID: 24481211 [TBL] [Abstract][Full Text] [Related]
7. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab. Alderman C; Corlett J; Cullis J Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440 [No Abstract] [Full Text] [Related]
8. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose. Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282 [TBL] [Abstract][Full Text] [Related]
9. Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia. Lupu A; Stefanescu C; Treton X; Attar A; Corcos O; Bouhnik Y J Clin Gastroenterol; 2013 Mar; 47(3):256-7. PubMed ID: 23164683 [TBL] [Abstract][Full Text] [Related]
10. Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia: An Evidence-based Review. Halderman AA; Ryan MW; Marple BF; Sindwani R; Reh DD; Poetker DM Am J Rhinol Allergy; 2018 Jul; 32(4):258-268. PubMed ID: 29745243 [TBL] [Abstract][Full Text] [Related]
11. Treatment of hereditary hemorrhagic telangiectasia with submucosal and topical bevacizumab therapy. Karnezis TT; Davidson TM Laryngoscope; 2012 Mar; 122(3):495-7. PubMed ID: 22147664 [TBL] [Abstract][Full Text] [Related]
12. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab. Fleagle JM; Bobba RK; Kardinal CG; Freter CE Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516 [TBL] [Abstract][Full Text] [Related]